Loading clinical trials...
Loading clinical trials...
The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous syst...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bracco Diagnostics, Inc
NCT05386108 · Breast Neoplasms, Brain Neoplasms, and more
NCT06954610 · Ischemic Stroke, Atrial Fibrillation, and more
NCT06871969 · Ischemic Stroke, Stroke, and more
NCT04286516 · Stroke, Brain Disease, and more
NCT06193252 · Parkinson Disease, Prodromal Stage, and more
Bracco Diagnostics, Inc.
Princeton, New Jersey
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions